Dermatologic Manifestations of Infection in the Compromised Host

  • Elaine T. Kaye
  • Richard Allen Johnson
  • John S. Wolfson
  • Arthur J. Sober


Among the most formidable challenges to the clinician is the care of the patient with an impaired immune system—the compromised host.1-4 Two characteristics in particular contribute to the complexity of management of infection in these patients: (1) the exceptionally broad variety of potential microbial pathogens and (2) the wide spectrum of clinical manifestations of disease resulting from the abnormal immune response.5–7


Herpes Zoster Candida Species Renal Transplant Recipient Acquire Immunodeficiency Syndrome Cutaneous Lesion 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Hill RB, Dahrling BE, Starzl TE, et al: Editorial: Death after transplantation. Am J Med 42: 327–334, 1967.PubMedGoogle Scholar
  2. 2.
    Anderson RJ, Schafer LA, Olin DB, et al: Infectious risk factors in the immunosuppressed host. Am J Med 54: 453–460, 1973.PubMedGoogle Scholar
  3. 3.
    Rubin RH, Young LS (eds): Clinical Approach to Infection in the Compromised Host, 1st ed. Plenum Press, New York, 1981.Google Scholar
  4. 4.
    Klastersky J (ed): Infections in Cancer Patients. European Organization for Research on Treatment of Cancer Monograph Series, Vol 10. Raven Press, New York, 1982.Google Scholar
  5. 5.
    Dale DC, Petersdorf RG: Corticosteroids and infectious diseases. Med Clin North Am 57: 1277–1287, 1973.PubMedGoogle Scholar
  6. 6.
    Dale DC: Defects in host defense mechanisms in compromised patients. In Rubin RH, Young LS (eds): Clinical Approach to Infection in the Compromised Host. Plenum Press, New York, 1981, pp. 35–74.Google Scholar
  7. 7.
    Wiernik PH: The management of infection in the cancer patient. JAMA 244: 185–192, 1980.PubMedGoogle Scholar
  8. 8.
    Haim S, Friedman-Birnbaum R, Better O, et al: Skin complications in immunosuppressed patients: Follow-up of kidney recipients. Br J Dermatol 89: 169–173, 1973.PubMedGoogle Scholar
  9. 9.
    Koranda F, Dehmel E, Kahn G, et al: Cutaneous complications in immunosuppressed renal homograft recipients. JAMA 229: 419–424, 1974.PubMedGoogle Scholar
  10. 10.
    Savin JA, Nobel WC: Immunosuppression and skin infection. Br J Dermatol 93: 115–120, 1975.PubMedGoogle Scholar
  11. 11.
    Rubin RH: Infection in the renal transplant patient. In Rubin RH, Young LS (eds): Clinical Approach to Infection in the Compromised Host. Plenum Press, New York, 1981, pp. 553–606.Google Scholar
  12. 12.
    Wolfson JS, Sober AJ, Rubin RH: Dermatologic manifestations of infection in the compromised host. Annu Rev Med 34: 205–217, 1983.PubMedGoogle Scholar
  13. 13.
    Wolfson JS, Sober AJ, Rubin RH: Dermatologic manifestations of infections in immunocompromised patients. Medicine (Baltimore) 64: 115–133, 1985.Google Scholar
  14. 14.
    Ray TL: Cutaneous signs of systemic disease: Fungal infections in the immunocompromised host. Med Clin North Am 64: 955–968, 1980.PubMedGoogle Scholar
  15. 15.
    Eickhoff T, Olin B, Anderson R, et al: Current problems and approaches to diagnosis of infection in renal transplant recipients. Transplant Proc 4: 613–697, 1972.Google Scholar
  16. 16.
    Notter D, Grossman P, Rosenberg S, et al: Infections in patients with Hodgkin’s disease: A clinical study of 300 consecutive adult patients. Rev Infect Dis 2: 761–800, 1980.PubMedGoogle Scholar
  17. 17.
    Bishop T, Schimpff S, Diggs C, et al: Infections during intensive chemotherapy for non-Hodgkin’s lymphoma. Ann Intern Med 95: 549–555, 1981.PubMedGoogle Scholar
  18. 18.
    Weinberg AN, Swartz MN: General considerations of bacterial diseases. In Fitzpatrick TB, Eisen AZ, Wolff K, et al (eds): Dermatology in General Medicine. McGraw-Hill, New York, 1979, pp. 1415–1426.Google Scholar
  19. 19.
    Prystowsky S, Vogelstein B, Ettinger D, et al: Invasive aspergillosis. N Engl J Med 295: 655–658, 1976.PubMedGoogle Scholar
  20. 20.
    Carlile JR, Millet RE, Cho CT, et al: Primary cutaneous aspergillosis in a leukemic child. Arch Dermatol 114: 78–80, 1978.PubMedGoogle Scholar
  21. 21.
    Gartenberg G, Bottone E, Keusch G, et al: Hospital-acquired mucormycosis (Rhizopus rhizopodiformis) of skin and subcutaneous tissue. N Engl J Med 299: 1115–1118, 1978.PubMedGoogle Scholar
  22. 22.
    Keys T, Haldorson A, Rhodes K, et al: Nosocomial outbreak of Rhizopus infections associated with Elastoplast wound dressings—Minnesota. Morb Mortal Wkly Rep 27: 33–34, 1978.Google Scholar
  23. 23.
    Sheldon DL, Johnson WC: Cutaneous mucormycosis: Two documented cases of suspected nosocomial cause. JAMA 241: 1032–1034, 1979.PubMedGoogle Scholar
  24. 24.
    Dennis JE, Rhodes KH, Cooney DR, et al: Nosocomial Rhizopus infection (zygomycosis) in children. J Pediatr 96: 824–828, 1980.PubMedGoogle Scholar
  25. 25.
    Biro L, Gibbs RC, Leider M: Staphylococcal infections: A study of incidence on a dermatologie ward. Arch Dermatol 82: 205–211, 1960.PubMedGoogle Scholar
  26. 26.
    Grossman ME, Fithian EC, Behrens C, et al: Primary cutaneous aspergillosis in six leukemic children. J Am Acad Dermatol 12: 313–318, 1985.PubMedGoogle Scholar
  27. 27.
    Granstein RD, First LR, Sober AJ: Primary cutaneous aspergillosis in a premature neonate. Br J Dermatol 103: 681–684, 1980.PubMedGoogle Scholar
  28. 28.
    Googe PB, DeCoste SD, Herold WH, et al: Primary cutaneous aspergillosis mimicking dermatophytosis. Arch Pathol Lab Med 113: 1284–1286, 1989.PubMedGoogle Scholar
  29. 29.
    Lorenzen I: The side effects of glucocorticoids on connective tissue. Acta Med Scand (Suppl) 50: 17–21, 1969.Google Scholar
  30. 30.
    Ray TL: Fungal infections in the immunocompromised host. Med Clin North Am 64: 955–969, 1980.PubMedGoogle Scholar
  31. 31.
    Smithers DW: Hodgkin’s disease. II. Br Med J 2: 337–340, 1967.PubMedGoogle Scholar
  32. 32.
    Mullen DL, Silverberg SG, Penn I, et al: Squamous cell carcinoma of the skin and lip in renal homograft recipients. Cancer 37: 729–734, 1976.PubMedGoogle Scholar
  33. 33.
    Hersh EM, Freireich EJ: Focus on cutaneous host-defense failure in transplant recipients. JAMA 229: 457–458, 1974.PubMedGoogle Scholar
  34. 34.
    McLelland J, Rees A, William G, et al: The incidence of immunosuppression-related skin disease in long-term transplant patients. Transplantation 46: 871–874, 1988.PubMedGoogle Scholar
  35. 35.
    Wilson CAB, Holmes SC, Campo MS, et al: Novel variants of human papillomavirus type 2 in warts from immunocompromised individuals. Br J Dermatol 121: 571–576, 1989.PubMedGoogle Scholar
  36. 36.
    Gassenmaier A, Fuchs P, Schell H, et al: Papillomavirus DNA in warts of immunosuppressed renal allograft recipients. Arch Dermatol Res 278: 219–223, 1986.PubMedGoogle Scholar
  37. 37.
    Spencer ES, Anderson HK: Clinically evident, non-terminal infections with herpesviruses and the wart virus in immunosuppressed renal allograft recipients. Br Med J 3: 215–254, 1970.Google Scholar
  38. 38.
    Hardie IR, Strong RW, Hartley CJ, et al: Skin cancer in Caucasian renal allograft recipients living in a subtropical climate. Surgery 87: 177–183, 1980.PubMedGoogle Scholar
  39. 39.
    Lutzner MA, Orth G, Dutronquay V, et al: Detection of human papillomavirus type 5 DNA in skin cancers of an immunosuppressed renal allograft recipient. Lancet 2: 422–424, 1983.PubMedGoogle Scholar
  40. 40.
    Dolin R, Reichman RC, Mazur MH, et al: NIH Conference: Herpes zoster-varicella infections in immunosuppressed patients. Ann Intern Med 89: 375–388, 1978.PubMedGoogle Scholar
  41. 41.
    Hirsch MS: Herpes group virus infections in the compromised host. In Rubin RH, Young LS (eds): Clinical Approach to Infection in the Compromised Host. Plenum Press, New York, 1981, pp. 389–415.Google Scholar
  42. 42.
    Lim W, Sadick N, Gupta A, et al: Skin diseases in children with HIV infection and their association with degree of immunosuppression. Int J Dermatol 29: 24–30, 1990.PubMedGoogle Scholar
  43. 43.
    Penneys NS: Cutaneous signs of AIDS. Dermatol Clin 7: 571–577, 1989.PubMedGoogle Scholar
  44. 44.
    Siegel FP, Lopez C, Hamer GS, et al: Severe acquired immunodeficiency in male homosexuals, manifested by chronic perianal ulcerative herpes simplex lesions. N Engl J Med 305: 1439–1444, 1981.Google Scholar
  45. 45.
    Gottlieb MS, Groopman JE, Weinstein WM, et al: UCLA Conference: The acquired immunodeficiency syndrome. Ann Intern Med 99: 208–220, 1983.PubMedGoogle Scholar
  46. 46.
    Chou S, Gallagher JG, Merigan TC: Controlled clinical trial of intravenous acyclovir in heart-transplant patients with mucocutaneous herpes simplex infection. Lancet 1: 1392–1394, 1981.PubMedGoogle Scholar
  47. 47.
    Mitchell CD, Bean B, Gentry SR, et al: Acyclovir therapy for mucocutaneous herpes simplex infections in immunocompromised patients. Lancet 1: 1389–1392, 1981.PubMedGoogle Scholar
  48. 48.
    Straus SE, Smith HA, Brickman C, et al: Acyclovir for chronic mucocutaneous herpes simplex virus infection in immunosuppressed patients. Ann Intern Med 96: 270–277, 1982.PubMedGoogle Scholar
  49. 49.
    Wade JC, Newton B, McLaren C, et al: Intravenous acyclovir to treat mucocutaneous herpes simplex virus infection after marrow transplantation: A double-blind trial. Ann Intern Med 96: 265–269, 1982.PubMedGoogle Scholar
  50. 50.
    Hirsh MS, Schooley RT: Treatment of herpesvirus infections. N Engl J Med 309: 963–970, 1034-1039, 1983.Google Scholar
  51. 51.
    Whitley RJ, Levin M, Barton N, et al: Infections caused by herpes simplex virus in the immunocompromised host: Natural history and topical acyclovir therapy. J Infect Dis 150: 323–329, 1984.PubMedGoogle Scholar
  52. 52.
    Wong KK, Hirsch MS: Herpesvirus infections in patients with neoplastic disease: Diagnosis and therapy. Am J Med 76: 464–478, 1984.PubMedGoogle Scholar
  53. 53.
    Safrin S, Assaykeen T, Follansbeen S, et al: Foscarnet therapy for acyclovir-resistant mucocutaneous herpes simplex virus infection in 26 AIDS patients: Preliminary data. J Infect Dis 161: 1078–1084, 1990.PubMedGoogle Scholar
  54. 54.
    Schimpff S, Serpick A, Stoler B, et al: Varicella-zoster infection in patients with cancer. Ann Intern Med 76: 241–254, 1972.PubMedGoogle Scholar
  55. 55.
    Meyers JD, Thomas ED: Infection complicating bone marrow transplantation. In Rubin RH, Young LS (eds): Clinical Approach to Infection in the Compromised Host. Plenum Press, New York, 1981, pp. 507–551.Google Scholar
  56. 56.
    Balfour HH, Bean B, Laskin OL, et al: Acyclovir halts progression of herpes zoster in immunosuppressed patients. N Engl J Med 308: 1448–1453, 1983.PubMedGoogle Scholar
  57. 57.
    Lesher JL: Cytomegalovirus infections and the skin. J Am Acad Dermatol 18: 1333–1338, 1988.PubMedGoogle Scholar
  58. 58.
    Toome BK, Bowers KE, Scott GA: Diagnosis of cutaneous cytomegalovirus infection: A review and report of a case. J Am Acad Dermatol 24: 860–867, 1991.PubMedGoogle Scholar
  59. 59.
    Jacobson MA, Mills J: Serious cytomegalovirus disease in the acquired immunodeficiency syndrome. Ann Intern Med 108: 558–594, 1988.Google Scholar
  60. 60.
    Horn TD, Hood AF: Clinically occult cytomegalovirus present in skin biopsy specimens in immunosuppressed hosts. J Am Acad Dermatol 21: 781–784, 1989.PubMedGoogle Scholar
  61. 61.
    Lee JYY: Cytomegalovirus infection involving the skin in immunocompromised hosts. Am J Clin Pathol 92: 96–100, 1989.PubMedGoogle Scholar
  62. 62.
    Rees AP, Meadors M, Ventura HO, et al: Diagnosis of disseminated cytomegalovirus infection and pneumonitis in a heart transplant recipient by skin biopsy: Case report. J Heart Lung Transplant 10: 329–332, 1991.PubMedGoogle Scholar
  63. 63.
    Fermand JP, Gozlan J, Bendelac A, et al: Detection of Epstein-Barr virus in epidermal skin lesions of an immunocompromised patient. Ann Intern Med 112: 511–515, 1990.PubMedGoogle Scholar
  64. 64.
    Alteras I, Aryeli G, Feuerman EJ: The prevalence of pathogenic and potentially pathogenic fungi on the apparently healthy skin of patients with neoplastic diseases. Mycopathologia 71: 85–87, 1980.PubMedGoogle Scholar
  65. 64a.
    Cho CT, Vats TS, Lowman JT, et al: Fusarium solani infection during treatment for acute leukemia. J Pediatr 83: 1028–1031, 1973.PubMedGoogle Scholar
  66. 64b.
    Farmer SG, Komorowski RA: Cutaneous microabscess formation from Alternaria alternata. Am J Clin Pathol 66: 565–569, 1976.PubMedGoogle Scholar
  67. 64c.
    Apaliski SJ, Moore MD, Reiner BJ, et al: Disseminated Trichosporon beigelii in an immunocompromised child. Pediatr Infect Dis 3: 451–454, 1984.PubMedGoogle Scholar
  68. 64d.
    Hernanz AD, Conde-Zurita JM, Pecharroman SR, et al: A case of Alternaria alternata (Fr.) Keissler infection of the knee. Clin Exp Dermatol 8: 641–646, 1983.Google Scholar
  69. 64e.
    Bourlond A, Alexandre G: Dermal alternariasis in a kidney transplant recipient. Dermatologia 168: 152–156, 1984.Google Scholar
  70. 65.
    Manzella JP, Berman IJ, Kukrilca MD: Trichosporon beigelii fungemia and cutaneous dissemination. Arch Dermatol 118: 343–345, 1982.PubMedGoogle Scholar
  71. 66.
    Horsburgh CR, Kirkpatrick CH: Long-term therapy of chronic mucocutaneous candidiasis with ketoconazole: Experience with 21 patients. Am J Med 74: 23–29, 1983.PubMedGoogle Scholar
  72. 67.
    Guerin V, Barbaud A, Duquenne M, et al: Cushing’s disease and cutaneous alternariosis. Arch Intern Med 151: 1865–1868, 1991.PubMedGoogle Scholar
  73. 68.
    Baker RL, Para MF: Successful use of ketoconazole for invasive cutaneous Trichophyton rubrum infection. Arch Intern Med 144: 615–617, 1984.PubMedGoogle Scholar
  74. 69.
    Dismukes WE, Stamm AM, Graybill JR, et al: Treatment of systemic mycoses with ketoconazole: Emphasis on toxicity and clinical response in 52 patients. Ann Inter Med 98: 13–20, 1983.Google Scholar
  75. 70.
    Galimberti RL, Flores V, Gonzalez Ramos MC, et al: Cutaneous ulcers due to Candida albicans in an immunocompromised patient—response to therapy with itraconazole. Clin Exp Dermatol 14: 295–297, 1989.PubMedGoogle Scholar
  76. 71.
    Uys CT, Don PA, Schire V, et al: Endocarditis following cardiac surgery due to the fungus Paecilomyces. S Afr Med J 37: 1276–1280, 1963.PubMedGoogle Scholar
  77. 72.
    Silver MD, Tuffnell PG, Bigelow WG: Endocarditis caused by Paecilomyces varioti affecting an aortic valve allograft. J Thorac Cardiovasc Surg 61: 278–281, 1971.PubMedGoogle Scholar
  78. 73.
    Haldane EV, MacDonald JL, Gittens WO, et al: Prosthetic valvular endocarditis due to the fungus Paecilomyces. Can Med Assoc J 111: 963–968, 1974.PubMedGoogle Scholar
  79. 74.
    McClellan JR, Hamilton JD, Alexander JA, et al: Paecilomyces varioti endocarditis on a prosthetic valve. J Thorac Cardivasc Surg 71: 472–475, 1976.Google Scholar
  80. 75.
    Mosier MA, Lusk B, Pettit TH, et al: Fungal endophthalmitis following intraocular lens implantation. Am J Ophthalmol 83: 1–8, 1977.PubMedGoogle Scholar
  81. 76.
    O’Day DM: Fungal endophthalmitis caused by Paecilomyces lilacinus after intraocular lens implantation. Am J Ophthalmol 83: 130–131, 1977.PubMedGoogle Scholar
  82. 77.
    Harris LF, Dan BM, Lefkowitz LB, et al: Paecilomyces cellulitis in a renal transplant patient: Successful treatment with intravenous miconazole. South Med J 72: 897–898, 1979.PubMedGoogle Scholar
  83. 78.
    Fogan L: Atypical mycobacteria. Medicine (Baltimore) 49: 243–255, 1970.Google Scholar
  84. 79.
    Kaplan MH, Armstrong D, Rosen P: Tuberculosis complicating neoplastic disease. Cancer 33: 850–858, 1974.PubMedGoogle Scholar
  85. 80.
    Wolinsky E: Nontuberculous mycobacteria and associated diseases. Am Rev Respir Dis 119: 107–158, 1979.PubMedGoogle Scholar
  86. 81.
    Beyt BE, Ortbals DW, Santa Cruz DJ, et al: Cutaneous mycobacteriosis: Analysis of 34 cases with a new classification of the disease. Medicine (Baltimore) 60: 95–109, 1981.Google Scholar
  87. 82.
    Lloveras J, Peterson PK, Simmons RL, et al: Mycobacterial infections in renal transplant recipients: Seven cases and a review of the literature. Arch Intern Med 142: 888–892, 1982.PubMedGoogle Scholar
  88. 83.
    Lichtenstein IH, MacGregor RR: Mycobacterial infections in renal transplant recipients: Report of five cases and review of the literature. Rev Infect Dis 5: 216–226, 1983.PubMedGoogle Scholar
  89. 84.
    Grice K: Sarcoidosis and Mycobacterium avium-intracellulare cutaneous abscesses. Clin Exp Dermatol 8: 323–327, 1983.PubMedGoogle Scholar
  90. 85.
    Wallace RJ, Swenson Jm, Silcox VA, et al: Spectrum of disease due to rapidly growing mycobacteria. Rev Infect Dis 5: 657–679, 1983.PubMedGoogle Scholar
  91. 86.
    Mehlmauer MA: Keratotic papules and nodules and hyperkeratosis of palms and soles in a patient with tuberculosis and AIDS-related complex. J Am Acad Dermatol 23: 381–385, 1990.PubMedGoogle Scholar
  92. 87.
    Stack RJ, Bickley LK, Coppel IG: Miliary tuberculosis presenting as skin lesions in a patient with acquired immunodeficiency syndrome. J Am Acad Dermatol 23: 1031–1035, 1990.PubMedGoogle Scholar
  93. 88.
    Davis BR, Brumback J, Sanders WJ, et al: Skin lesions caused by Mycobacterium haemophilum. Ann Intern Med 97: 723–724, 1982.PubMedGoogle Scholar
  94. 89.
    Murdoch ME, Leigh IM: Sporotrichoid spread of cutaneous Mycobacterium chelonei infection. Clin Exp Dermatol 14: 309–312, 1989.PubMedGoogle Scholar
  95. 89a.
    Bolivar R, Salterwhite TK, Floyd M: Cutaneous lesions due to Mycobacterium kansasii. Arch Dermatol 116: 207–208, 1980.PubMedGoogle Scholar
  96. 89b.
    Heironimus JD, Winn RE, Collins CB: Cutaneous non-pulmonary Mycobacterium chelonei infection. Arch Dermatol 120: 1061–1063, 1984.PubMedGoogle Scholar
  97. 89c.
    Cross GM, Guill MA, Aton JK: Cutaneous Mycobacterium szulgai infection. Arch Dermatol 121: 247–249, 1985.PubMedGoogle Scholar
  98. 90.
    Barbara DJ, Orcutt VL, Coldiron BM: Mycobacterium avium-Mycobacterium intracellulare infection limited to the skin and lymph nodes in patients with AIDS. Rev Infect Dis 11: 625–628, 1989.Google Scholar
  99. 91.
    Gombert ME, Goldstein EJC, Corrado ML, et al: Disseminated Mycobacterium marinum infection after renal transplantation. Ann Intern Med 94: 486–487, 1981.PubMedGoogle Scholar
  100. 92.
    Davies RR, Wilkinson JL: Human protothecosis: Supplementary studies. Ann Trop Med Parasitol 61: 112–115, 1967.PubMedGoogle Scholar
  101. 93.
    Tindall JP, Fetter BF: Infections caused by achloric algae (protothecosis). Arch Dermatol 104: 490–500, 1971.PubMedGoogle Scholar
  102. 94.
    Cox GE, Wilson JD, Brown P: Protothecosis: A case of disseminated algal infection. Lancet 2: 379–382, 1974.PubMedGoogle Scholar
  103. 95.
    Sudman MS: Protothecosis: A critical review. Am J Clin Pathol 61: 10–19, 1974.PubMedGoogle Scholar
  104. 96.
    Mayhall CG, Miller CW, Eisen AZ, et al: Cutaneous protothecosis: Successful treatment with amphotericin B. Arch Dermatol 112: 1749–1752, 1976.PubMedGoogle Scholar
  105. 97.
    Wolfe ID, Sacks HG, Samorodin CS, et al: Cutaneous protothecosis in a patient receiving immunosuppressive therapy. Arch Dermatol 112: 829–832, 1976.PubMedGoogle Scholar
  106. 98.
    Dagher FJ, Smith AG, Pankoski D, et al: Skin protothecosis in a patient with renal allograft. South Med J 71: 222–224, 1978.PubMedGoogle Scholar
  107. 99.
    Phair JP, Williams JE, Bassaris HP, et al: Phagocytosis and algicidal activity of human polymorphonuclear neutrophils against Prototheca wickerhamii. J Infect Dis 144: 72–76, 1981.PubMedGoogle Scholar
  108. 100.
    Venezio FR, Lavoo E, Williams JE, et al: Progressive cutaneous protothecosis. Am J Clin Pathol 77: 485–493, 1982.PubMedGoogle Scholar
  109. 101.
    Pegram PS, Kerns FT, Wasilauskas BL, et al: Successful ketoconazole treatment of protothecosis with ketoconazole-associated hepatotoxicity. Arch Intern Med 143: 1802–1805, 1983.PubMedGoogle Scholar
  110. 102.
    Vernon SE, Goldman LS: Protothecosis in the Southeastern United States. South Med J 76: 949–950, 1983.PubMedGoogle Scholar
  111. 103.
    Klintworth GK, Fetter BF, Nielsen HS: Protothecosis — An algal infection: Report of a case in man. J Med Microbiol 1: 211–216, 1968.PubMedGoogle Scholar
  112. 104.
    Langlois RP, Flegel KM, Meakins JL, et al: Cutaneous aspergillosis with fatal dissemination in a renal transplant recipient. Can Med J 22: 673–676, 1980.Google Scholar
  113. 105.
    Lehrer RI, Howard DH, Sypherd PS, et al: UCLA conference: Mucormycosis. Ann Intern Med 93: 93–108, 1980.Google Scholar
  114. 106.
    Fisher J, Tuazon CU, Geelhoed GW: Mucormycosis in transplant patients. Am Surg 46: 315–322, 1980.PubMedGoogle Scholar
  115. 107.
    Bateman CP, Umland ET, Becker LE: Cutaneous zygomycosis in a patient with lymphoma. J Am Acad Dermatol 8: 890–894, 1983.PubMedGoogle Scholar
  116. 108.
    Young RC, Bennett FE, Vogel CL, et al: Aspergillosis: The spectrum of the disease in 98 patients. Medicine (Baltimore) 49: 147–173, 1970.Google Scholar
  117. 109.
    Meyer RD, Rosen P, Armstrong D: Phycomycosis complicating leukemia and lymphoma. Ann Intern Med 77: 871–879, 1972.PubMedGoogle Scholar
  118. 110.
    Forkner CE, Frei E, Edgecomb JH, et al: Pseudomonas septicemia: Observations on twenty-three cases. Am J Med 25: 877–889, 1968.Google Scholar
  119. 111.
    Bagel J, Grossman ME: Subcutaneous nodules in Pseudomonas sepsis. Am J Med 80: 528–529, 1986.PubMedGoogle Scholar
  120. 112.
    Picou KA, Jarratt MT: Persistent subcutaneous abscesses following Pseudomonas sepsis. Arch Dermatol 115: 459–460, 1979.PubMedGoogle Scholar
  121. 113.
    Llistosella E, Ravella A, Moreno A, et al: Panniculitis in Pseudomonas aeruginosa septicemia. Acta Dermatol Venereol (Stockholm) 64: 447–449, 1984.Google Scholar
  122. 114.
    Fergie JE, Patrick CC, Lott L: Pseudomonas aeruginosa cellulitis and ecthyma gangrenosum in immunocompromised children. Pediatr Infect Dis J 10: 496–500, 1991.PubMedGoogle Scholar
  123. 115.
    Greene SL, Su WP, Muller SA: Ecthyma gangrenosum: Report of clinical, histopathologic, and bacteriologic aspects of eight cases. J Am Acad Dermatol 11: 781–787, 1984.PubMedGoogle Scholar
  124. 115a.
    Fine JD, Miller JA, Harrist TJ, et al: Cutaneous lesions in disseminated candidiasis mimicking ecthyma gangrenosum. Am J Med 70: 1133–1135, 1981.PubMedGoogle Scholar
  125. 115b.
    Umbert IJ, Su WPD: Cutaneous mucormycosis. J Am Acad Dermatol 21: 1232–1234, 1989.PubMedGoogle Scholar
  126. 116.
    Park RK, Goltz RW, Carey TB: Unusual cutaneous infections associated with immunosuppressive therapy. Arch Dermatol 95: 345–350, 1967.PubMedGoogle Scholar
  127. 117.
    O’Dorisio TM, Jasper DA, Sullivan J: A cutaneous manifestation of untreated disseminated histoplasmosis. Chest 67: 616–617, 1975.PubMedGoogle Scholar
  128. 118.
    Studdard J, Sneed WF, Taylor MR, et al: Cutaneous histoplasmosis. Am Rev Respir Dis 113: 689–693, 1976.PubMedGoogle Scholar
  129. 119.
    Daman LA, Hashimoto K, Kaplan RJ, et al: Disseminated histoplasmosis in an immunosuppressed patient. South Med J 70: 355–356, 1977.PubMedGoogle Scholar
  130. 120.
    Cott GR, Smith TW, Hinthom DR, et al: Primary cutaneous histoplasmosis in immunosuppressed patients. JAMA 242: 456–457, 1979.PubMedGoogle Scholar
  131. 121.
    Johnston CA, Tank CK, Jiji R: Histoplasmosis of skin and lymph nodes and chronic lymphocytic leukemia. Arch Dermatol 115: 336–337, 1979.PubMedGoogle Scholar
  132. 122.
    Davies SR, Sarosi GA, Peterson PK, et al: Disseminated histoplasmosis in renal transplant recipients. Am J Surg 137: 686–691, 1979.PubMedGoogle Scholar
  133. 123.
    Goodwin RA, Shapiro JL, Thurman GH, et al: Disseminated histoplasmosis: Clinical and pathologic correlations. Medicine (Baltimore) 59: 1–33, 1980.Google Scholar
  134. 124.
    Cohen PR, Bank DE, Silvers DN, et al: Cutaneous lesions of disseminated histoplasmosis in human immunodeficiency virus-infected patients. J Am Acad Dermatol 23: 442–448, 1990.Google Scholar
  135. 125.
    Cohen PR, Grossman ME, Silvers DN: Disseminated histoplasmosis and human immunodeficiency virus infection. Int J Dermatol 30: 614–622, 1991.PubMedGoogle Scholar
  136. 126.
    Hazelhurst JA, Vismer HF: Histoplasmosis presenting with unusual skin lesions in acquired immunodeficiency syndrome (AIDS). Br J Dermatol 113: 345–348, 1985.PubMedGoogle Scholar
  137. 127.
    Greenberg RG, Berger TG: Progressive disseminated histoplasmosis in acquired immune deficiency syndrome: Presentation as a steroid-responsive dermatosis. Cutis 43: 535–538, 1989.PubMedGoogle Scholar
  138. 128.
    Johnson PC, Khardori N, Najjar AF, et al: Progressive disseminated histoplasmosis in patients with acquired immune deficiency syndrome. Am J Med 85: 152–158, 1988.PubMedGoogle Scholar
  139. 129.
    Hobbs ER: Coccidioidomycosis. Dermatol Clin 7: 227–239, 1989.PubMedGoogle Scholar
  140. 130.
    Farr B, Beacham BE, Atuk NO: Cutaneous histoplasmosis after renal transplantation. South Med J 74: 635–637, 1981.PubMedGoogle Scholar
  141. 131.
    Palmer DL, Harvey RL, Wheeler JK: Diagnostic and therapeutic considerations in Nocardia asteroudes infection. Medicine (Baltimore) 53: 391–401, 1974.Google Scholar
  142. 132.
    Frazier AR, Rosenow EC, Roberts GD: Nocardiosis: A review of 25 cases occurring during 24 months. Mayo Clin Proc 50: 657–663, 1975.PubMedGoogle Scholar
  143. 133.
    Beaman BL, Burnside J, Edwards B, et al: Nocardial infections in the United Sates, 1972-1974. J Infect Dis 134: 286–289, 1976.PubMedGoogle Scholar
  144. 134.
    Brown E, Freedman S, Arbeit R, et al: Invasive pulmonary aspergillosis in an apparently non-immunocompromised host. Am J Med 69: 624–627, 1980.PubMedGoogle Scholar
  145. 135.
    Fisher BD, Armstrong D, Yu B, et al: Invasive aspergillosis: Prognosis in early diagnosis and treatment. Am J Med 71: 571–577, 1981.PubMedGoogle Scholar
  146. 136.
    Kerkering TM, Duma RJ, Shadomy S: The evolution of pulmonary cryptococcosis. Ann Intern Med 94: 611–616, 1981.PubMedGoogle Scholar
  147. 137.
    Myskowski PL, Brown AE, Dinsmore R, et al: Mucormycosis following bone marrow transplantation. J Am Acad Dermatol 9: 111–115, 1983.PubMedGoogle Scholar
  148. 138.
    Perfect JR, Durack DT, Gallis HA: Cryptococcemia. Medicine (Baltimore) 62: 98–109, 1983.Google Scholar
  149. 138a.
    Lewis JL, Rabinovich S: The wide spectrum of cryptococcal infections. Am J Med 53: 315–322, 1972.PubMedGoogle Scholar
  150. 139.
    Rinaldi MG: Invasive aspergülosis. Rev Infect Dis 5: 1061–1077, 1983.PubMedGoogle Scholar
  151. 140.
    Sarosi GA, Silberfarb PM, Tosh FE: Cutaneous cryptococcosis: A sentinel of disseminated disease. Arch Dermatol 104: 1–3, 1971.PubMedGoogle Scholar
  152. 141.
    Meyer RD, Kaplan MH, Ong M, et al: Cutaneous lesions in disseminated mucormycosis. JAMA 225: 737–738, 1973.PubMedGoogle Scholar
  153. 142.
    Schupbach CW, Wheeler CE, Briggaman RA, et al: Cutaneous manifestations of disseminated cryptococcosis. Arch Dermatol 112: 1734–1740, 1976.PubMedGoogle Scholar
  154. 143.
    Kramer BS, Hernandez AD, Reddick RL, et al: Cutaneous infarction: Manifestation of disseminated mucormycosis. Arch Dermatol 113: 1075–1076, 1977.PubMedGoogle Scholar
  155. 144.
    Greene MH, Macher AM, Hernandez AD, et al: Disseminated cryptococcosis presenting as palpable purpura. Arch Intern Med 138: 1412–1413, 1978.PubMedGoogle Scholar
  156. 145.
    Simpson GL, Stinson EB, Egger MJ, et al: Nocardial infections in the immunocompromised host: A detailed study in a defined population. Rev Infect Dis 3: 492–507, 1981.PubMedGoogle Scholar
  157. 146.
    Bernhardt MJ, Ward WQ, Sams WM: Cryptococcal cellulitis. Cutis 34: 359–361, 1984.PubMedGoogle Scholar
  158. 146a.
    Moore M: Cryptococcus with cutaneous manifestations. J Invest Dermatol 28: 159–182, 1957.PubMedGoogle Scholar
  159. 147.
    Azon-Masoliver A, Gonzalez-Clemente J, Pedrol E, et al: Herpetiform and mollusca contagiosa-like cutaneous cryptococcosis in a patient with AIDS. Br J Dermatol 121: 665–667, 1989.PubMedGoogle Scholar
  160. 148.
    Picon L, Vaillant L, Duong T, et al: Cutaneous cryptococcosis resembling molluscum contagiosum: A first manifestation of AIDS. Acta Dermatol Venereol (Stockholm) 69: 365–367, 1989.Google Scholar
  161. 149.
    Jones C, Orengo I, Rosen T, et al: Cutaneous cryptococcosis simulating Kaposi’s sarcoma in the acquire immunodeficiency syndrome. Cutis 45: 163–167, 1990.PubMedGoogle Scholar
  162. 150.
    Shuttleworth D, Philpot CM, Knight AG: Cutaneous cryptococcosis: Treatment with oral fluconazole. Br J Dermatol 120: 683–687, 1989.PubMedGoogle Scholar
  163. 151.
    Bodey GP, Luna M: Skin lesions associated with disseminated candidiasis. JAMA 229: 1466–1468, 1974.PubMedGoogle Scholar
  164. 152.
    Wingard JR, Merz WG, Saral R: Candida tropicalis: A major pathogen in immunocompromised patients. Ann Intern Med 91: 539–543, 1979.PubMedGoogle Scholar
  165. 153.
    Louria DB, Stiff DP, Bennett B: Disseminated moniliasis in the adult. Medicine (Baltimore) 41: 307–337, 1962.Google Scholar
  166. 154.
    DeVita VT, Utz JP, Williams T, et al: Candida meningitis. Arch Intern Med 117: 527–535, 1966.PubMedGoogle Scholar
  167. 155.
    Curry CR, Quie PG: Fungal septicemia in patients receiving parenteral hyperalimentation. N Engl J Med 285: 1221–1225, 1971.PubMedGoogle Scholar
  168. 156.
    Bayer AS, Edwards JE, Seidel JS, et al: Candida meningitis: Report of seven cases and review of the English literature. Medicine (Baltimore) 55: 447–486, 1976.Google Scholar
  169. 157.
    Myerowitz RL, Pazin GJ, Allen CM: Disseminated candidiasis: Changes in incidence, underlying diseases, and pathology. Am J Clin Pathol 68: 29–38, 1977.PubMedGoogle Scholar
  170. 158.
    Balandran L, Rothschild H, Pugh N, et al: A cutaneous manifestation of systemic candidiasis. Ann Intern Med 78: 400–403, 1973.PubMedGoogle Scholar
  171. 159.
    Edwards JE, Lehrer RI, Stiehm ER, et al: UCLA Conference: Severe candidal infections—Clinical perspective, immune defense mechanisms, and current concepts of therapy. Ann Intern Med 89: 91–106, 1978.PubMedGoogle Scholar
  172. 160.
    Jarowski CI, Fialk MA, Murray HW, et al: Fever, rash, and muscle tenderness: A distinctive clinical presentation of disseminated candidiasis. Arch Intern Med 138: 544–546, 1978.PubMedGoogle Scholar
  173. 161.
    Kressel B, Szewczyk C, Tuazon CU: Early clinical recognition of disseminated candidiasis by muscle and skin biopsy. Arch Intern Med 138: 429–433, 1978.PubMedGoogle Scholar
  174. 162.
    Grossman ME, Silvers DN, Walther RR: Cutaneous manifestations of disseminated candidiasis. J Am Acad Dermatol 2: 111–116, 1980.PubMedGoogle Scholar
  175. 163.
    Jacobs MI, Magid MS, Jarowski CL: Disseminated candidiasis: Newer approaches to early recognition and treatment. Arch Dermatol 116: 1277–1279, 1980.PubMedGoogle Scholar
  176. 164.
    Arena FP, Perlin M, Brahman H, et al: Fever, rash, and myalgias of disseminated candidiasis during antifungal therapy. Arch Intern Med 141: 1233, 1981.PubMedGoogle Scholar
  177. 165.
    Suster S, Rosen LB: Intradermal bullous dermatitis due to candidiasis in an immunocompromised patient. JAMA 258: 2106–2107, 1987.PubMedGoogle Scholar
  178. 166.
    Curley RK, Hayward T, Holden CA: Cutaneous abscesses due to systemic nocardiosis—a case report. Clin Exp Dermatol 15: 459–461, 1990.PubMedGoogle Scholar
  179. 167.
    Smego RA, Gallis HA: The clinical spectrum of Nocardia brasiliensis infection in the United States. Rev Infect Dis 6: 164–180, 1984.PubMedGoogle Scholar
  180. 168.
    Fauci AS, Macher AM, Longo DL, et al: NIH conference: Acquired immunodeficiency syndrome—Epidemiologic, clinical, immunologic, and therapeutic considerations. Ann Intern Med 100: 92–106, 1984.PubMedGoogle Scholar
  181. 169.
    Jaffe HS, Abrams DI, Ammarm AJ, et al: Complications of cotrimoxazole in treatment of AIDS-associated Pneumocystis carinii pneumonia in homosexual men. Lancet 2: 1109–1111, 1983.PubMedGoogle Scholar
  182. 170.
    Mitsuyasu R, Groopman J, Volberding P: Cutaneous reaction to trimethoprim-sulfamethoxazole in patients with AIDS and Kaposi’s sarcoma. N Engl J. Med 308: 1535–1536, 1983.PubMedGoogle Scholar
  183. 171.
    Gordin FM, Simon GL, Wofsy CB, et al: Adverse reactions to trimethoprim—sulfamethoxazole in patients with the acquired immunodeficiency syndrome. Ann Intern Med 100: 495–499, 1984.PubMedGoogle Scholar
  184. 172.
    Ziegler JL, Beckstead JA, Volberding PA, et al: Non-Hodgkin’s lymphoma in 90 homosexual men: Relation to generalized lymphadenopathy and the acquired immunodeficiency syndrome. N Engl J Med 311: 565–570, 1984.PubMedGoogle Scholar
  185. 173.
    Lind SE, Gross PL, Andiman WA, et al: Malignant lymphoma presenting as Kaposi’s sarcoma in a homosexual man with acquired immunodeficiency syndrome. Ann Intern Med 102: 338–340, 1985.PubMedGoogle Scholar
  186. 174.
    Morris L, Distenfeld A, Amorosi E, et al: Autoimmune thrombocytopenic purpura in homosexual men. Ann Intern Med 96: 714–717, 1982.PubMedGoogle Scholar
  187. 175.
    Eisenstat BA, Wormser GP: Seborrheic dermatitis and butterfly rash in AIDS. N Engl J Med 311: 189, 1984.PubMedGoogle Scholar
  188. 176.
    Abramson SB, Odajnyk CM, Grieco AJ, et al: Hyperalgesic pseudothrombophlebitis: New syndrome in male homosexuals. Am J Med 78: 317–320, 1985.PubMedGoogle Scholar
  189. 177.
    Sandor E, Croxson TS, Millman A, et al: Herpes zoster ophthalmicus in patients at risk of AIDS. N Engl J Med 310: 1118–1119, 1984.PubMedGoogle Scholar
  190. 178.
    Ho DD, Murata GH: Streptococcal lymphadenitis in homosexual men with chronic lymphadenopathy. Am J Med 77: 151–153, 1984.PubMedGoogle Scholar
  191. 179.
    Holtz HA, Lavery DP, Kapila R: Actinomycetales infection in the acquired immunodeficiency syndrome. Ann Intern Med 102: 203–205, 1985.PubMedGoogle Scholar
  192. 180.
    Macher AM, Kovars JA, Gill V, et al: Bacteremia due to Mycobacterium avium—intracellulare in the acquired immunodeficiency syndrome. Ann Intern Med 99: 782–785, 1983.PubMedGoogle Scholar
  193. 181.
    Melbye M, Grossman RJ, Goedert JJ, et al: Risk of AIDS after herpes zoster. Lancet 1: 728–730, 1987.PubMedGoogle Scholar
  194. 182.
    Mosca JD, Bednank DP, Raj NBK, et al: Activation of human immunodeficiency virus by herpesvirus infection: Identification of a region with the long terminal repeat that responds to a transacting factor encoded by herpes simplex virus. Proc Natl Acad Sci USA 84: 7408–7412, 1987.PubMedGoogle Scholar
  195. 183.
    Coulman CU, Greene I, Archibald RWR: Cutaneous pneumocystosis. Ann Intern Med 106: 396–398, 1987.PubMedGoogle Scholar
  196. 184.
    Hennessey NP, Parro EL, Cockerell CJ: Cutaneous Pneumocystis carinii infection in patients with acquired immunodeficiency syndrome. Arch Dermatol 127: 1699–1701, 1991.PubMedGoogle Scholar
  197. 185.
    Szaniawski WK, Don PC, Bitterman SR, et al: Epithelioid angiomatosis in patients with AIDS: Report of seven cases and review of the literature. J Am Acad Dermatol 23: 41–48, 1990.PubMedGoogle Scholar
  198. 186.
    Rudikoff D, Phelps RG, Gordon RE, et al: Acquired immunodeficiency syndrome-related bacillary vascular proliferation (epithelioid angiomatosis): Rapid response to erythromycin therapy. Arch Dermatol 125: 706–707, 1989.PubMedGoogle Scholar
  199. 187.
    Mui BS, Mulligan ME, George WL: Response of HIV-associated disseminated cat scratch disease to treatment with doxycycline. Am J Med 89: 229–231, 1990.PubMedGoogle Scholar
  200. 188.
    Koehler JE, Tappero JW: Bacillary angiomatosis and peliosis in patients infected with human immunodeficiency virus. Clin Infect Dis 17: 612–624, 1993.PubMedGoogle Scholar
  201. 189.
    Relman DA, Falkow S, LeBoit PE: The organism causing bacillary angiomatosis, Peliosis hepatis, and fever and bacteremia in immunocompromised patients. N Engl J Med 324: 1514–1519, 1991.PubMedGoogle Scholar
  202. 190.
    Wilson CB, Siber GR, O’Brien TF, et al: Phycomycotic gangrenous cellulitis. Arch Surg 111: 532–538, 1976.PubMedGoogle Scholar
  203. 191.
    Lomvardias S, Madge GE: Chaetoconidium and atypical acidfast bacilli in skin ulcers. Arch Dermatol 106: 875–876, 1972.Google Scholar
  204. 192.
    Sanderson TL, Moskowitz L, Hensley GT, et al: Disseminated Mycobacterium avium-intracellulare infection appearing as a panniculitis. Arch Pathol Lab Med 106: 112–114, 1982.PubMedGoogle Scholar
  205. 193.
    Zaatari GS, Reed R, Morewessel R: Subcutaneous hyphomycosis caused by Scytalidium hyalinum. Am J Clin Pathol 82: 252–256, 1984.PubMedGoogle Scholar
  206. 194.
    Baker RD, Seabury JH, Schneidau JD: Subcutaneous and cutaneous mucormycosis and subcutaneous phycomycosis. Lab Invest 11: 1091–1102, 1962.PubMedGoogle Scholar
  207. 195.
    Helm TN, Mazanec D: Disseminated aspergillosis presenting as a skin abscess. Cleveland Clin J. Med 57: 92–94, 1990.Google Scholar
  208. 196.
    Ries KM, White GL, Murdock RT: Atypical mycobacterial infection caused by Mycobacterium marinum. N Engl J Med 322: 633, 1990.PubMedGoogle Scholar
  209. 197.
    Stellbrink HJ, Koperski K, Albrecht H, et al: Mycobacterium kansasii infection limited to skin and lymph node in a patient with AIDS. Clin Exp Dermatol 15: 457–458, 1990.PubMedGoogle Scholar
  210. 198.
    Gannon M, Otridge B, Hone R, et al: Cutaneous Mycobacterium malmoense infection in an immunocompromised patient. Int J Dermatol 29: 149–150, 1990.PubMedGoogle Scholar
  211. 199.
    Mowbray DN, Palier AS, Nelson PE, et al: Disseminated Fusarium solani infection with cutaneous nodules in a bone marrow transplant patient. Int J Dermatol 27: 698–701, 1988.PubMedGoogle Scholar
  212. 200.
    Sneeringer RM, Haas DW: Cutaneous Alternaria infection in a patient on chronic corticosteroids. J Tenn Med Assoc 83: 15–17, 1990.PubMedGoogle Scholar
  213. 201.
    Patterson JW, Brown PC, Broecker AH: Infection-induced panniculitis. J Cutan Pathol 16: 183–193, 1989.PubMedGoogle Scholar
  214. 202.
    Silverman AK, Gilbert SC, Watkins D, et al: Panniculitis in an immunocompromised patient. J Am Acad Dermatol 24: 912–914, 1991.PubMedGoogle Scholar

Copyright information

© Plenum Publishing Corporation 1994

Authors and Affiliations

  • Elaine T. Kaye
    • 1
    • 2
  • Richard Allen Johnson
    • 2
    • 3
  • John S. Wolfson
    • 4
    • 5
  • Arthur J. Sober
    • 5
    • 6
  1. 1.Department of DermatologyMassachusetts General HospitalBostonUSA
  2. 2.Harvard Medical SchoolBostonUSA
  3. 3.Department of DermatologyMassachusetts General Hospital, New England Deaconess HospitalBostonUSA
  4. 4.Infectious Disease Unit, Medical ServicesMassachusetts General HospitalBostonUSA
  5. 5.Department of MedicineHarvard Medical SchoolBostonUSA
  6. 6.Dermatology ServiceMassachusetts General HospitalUSA

Personalised recommendations